Clinical Study
Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer
Table 2
Compliance of patients.
| Characteristic | Patients () |
| Total radiation dose (Gy) | | ≥60 | 111 (94.9) | <60 | 6 (5.1) | Number of weekly chemotherapy (cycle) | | ≤4 | 14 (12.0) | 5 | 15 (12.8) | 6 | 48 (41.0) | 7 | 37 (31.6) | 8 | 3 (2.6) | Admission during CCRT | | Never | 97 (82.9) | Admission more than 5 days | 20 (17.1) |
|
|